These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4838914)

  • 1. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL; Weiner WJ
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):427-30. PubMed ID: 4838914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW; Deze J; Gundlach U; Muschard F
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ; Elizan TS; Siegel GJ
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):668-73. PubMed ID: 5158780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ; Elizan TS; Siegel G
    Trans Am Neurol Assoc; 1970; 95():286-7. PubMed ID: 5514393
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of dystonia with L-dopa and haloperidol.
    Mandell S
    Neurology; 1970 Nov; 20(11):103-6. PubMed ID: 5529471
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease.
    Mones RJ; Elizan TS; Siegel GJ
    Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
    Chase TN; Holden EM; Brody JA
    Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C
    Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534982
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol in dopa-induced choreo-athetosis.
    Postma JU
    Psychiatr Neurol Neurochir; 1972; 75(1):69-71. PubMed ID: 5024898
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

  • 13. Laevo-dopa for Parkinsonism.
    Jenkins R
    Br Med J; 1970 May; 2(5705):361-2. PubMed ID: 5429465
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa for parkinsonism.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 16. Akinesis following stereotactic surgery for Parkinsonism. The use of L-dopa.
    Ahmad R; Gillingham FJ; Hanieh A; Pullar IA; Weddell J; Ashcroft G
    Confin Neurol; 1970; 32(2):128-34. PubMed ID: 4926177
    [No Abstract]   [Full Text] [Related]  

  • 17. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E
    Neurology; 1974 Feb; 24(2):116-9. PubMed ID: 4855678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa].
    Sigwald J; Raymondeaud C
    Rev Neurol (Paris); 1970 Feb; 122(2):103-12. PubMed ID: 4397165
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
    Jenkins AC; Schwieger AC
    Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.